Microvesicles - potential biomarkers for the interrelations atherosclerosis/type 2 diabetes mellitus.

Microvesicles, also called microparticles or exosomes, are ultrastructural cellular components that have been widely researched in the past as well as present in order to establish their morphology, origin and role in physiological and pathological processes. Advanced techniques show that these microparticles have their clinical implications in the prevention and prediction in pathology and have potential in the discovery of novel therapeutic approaches to metabolic diseases such as diabetes, cardiovascular, autoimmune diseases and cancer.